Whipplewood Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21K Sell
10
-77
-89% -$21.3K ﹤0.01% 410
2026
Q1
$25.7K Buy
87
+83
+2,075% +$24.7K 0.01% 355
2025
Q4
$1.09K Buy
+4
New +$1.09K ﹤0.01% 401
2025
Q3
Sell
-161
Closed -$44.4K 469
2025
Q2
$44.4K Buy
161
+16
+11% +$4.35K 0.02% 332
2025
Q1
$41.9K Sell
145
-13
-8% -$3.21K 0.02% 330
2024
Q4
$36.7K Buy
+158
New +$36.3K 0.02% 356

Other funds holding CME

Whipplewood Advisors's CME Position: Q2 2026 in Review

Whipplewood Advisors reduced its CME Group (CME) stake by 89% in Q2 2026, selling an estimated $21.3K and leaving 10 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Whipplewood Advisors first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.4K in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Whipplewood Advisors held 10 shares of CME Group worth $2.21K as of Q2 2026.
  • Whipplewood Advisors sold 77 CME Group shares in Q2 2026, an estimated $21.3K.
  • CME Group made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #410 holding.
  • Whipplewood Advisors first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's CME Group position peaked at $44.4K in Q2 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.